Literature DB >> 7913814

HIV infection of human fetal intestinal explant cultures induces epithelial cell proliferation.

P A Batman1, S C Fleming, P M Sedgwick, T T MacDonald, G E Griffin.   

Abstract

OBJECTIVE: The concept that HIV infection per se alters small intestinal mucosal structure and function (HIV enteropathy) remains controversial and in this study we report in vitro experiments designed to elucidate the matter.
METHODS: Twenty pairs of human fetal intestinal tissue explants were maintained in vitro for up to 14 days; one explant of each pair was incubated and infected with HIV, and the other served as a matched uninfected control. At various times after infection, explant culture fluid and tissue were removed, p24 concentration was measured and tissue formalin fixed. Explant tissue was embedded in paraffin wax and sections stained by an immunoperoxidase method directed against proliferating cell nuclear antigen (PCNA). The percentage of proliferating crypt and villous epithelial cells, stained by PCNA, was calculated in paired samples. The difference between the percentage for paired samples was designated delta crypt proliferation (delta CP) and delta villous proliferation (delta VP), respectively. Epithelial cell proliferation was deemed to be enhanced if the percentage of PCNA-stained cells was greater in the HIV-infected than in the control tissue.
RESULTS: Explant culture fluid from tissue exposed to HIV showed a progressive rise in p24 antigen (Ag) level, indicating HIV infection of these explants. Fifteen pairs of explants showed progressively positive delta CP with time (P < 0.01) indicating crypt hyperplasia and all 20 pairs of explants showed positive delta VP, indicating hyperplasia of villous epithelial cells.
CONCLUSIONS: This study provides direct evidence that HIV stimulates epithelial cell proliferation in intestinal mucosa. HIV-infected human intestinal explants provide a model of crypt hyperplastic villous atrophy previously described as HIV enteropathy and detected in clinical biopsy specimens from HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913814

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report.

Authors:  Brandi Giovanni; Carlo Calabrese; Roberto Manfredi; Anna Maria Pisi; Giulio Di Febo; Rossella Hakim; Giovanna Cenacchi; Guido Biasco
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

2.  HIV enteropathy: comparative morphometry of the jejunal mucosa of HIV infected patients resident in the United Kingdom and Uganda.

Authors:  P A Batman; M S Kapembwa; A R Miller; P M Sedgwick; S Lucas; N K Sewankambo; D Serwadda; J Pudney; A Moody; J R Harris; G E Griffin
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 3.  Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract.

Authors:  T Schneider; R Ullrich; M Zeitz
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage.

Authors:  P Kelly; S E Davies; B Mandanda; A Veitch; G McPhail; I Zulu; F Drobniewski; D Fuchs; C Summerbell; N P Luo; J O Pobee; M J Farthing
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

5.  EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool.

Authors:  Evan Colletti; Deena El Shabrawy; Melisa Soland; Takashi Yamagami; Saloomeh Mokhtari; Craig Osborne; Karen Schlauch; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  FASEB J       Date:  2013-02-14       Impact factor: 5.191

Review 6.  HIV infection and the gastrointestinal immune system.

Authors:  J M Brenchley; D C Douek
Journal:  Mucosal Immunol       Date:  2008-01       Impact factor: 7.313

7.  Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum.

Authors:  L van der Hoek; R Boom; J Goudsmit; F Snijders; C J Sol
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

8.  Unexplained diarrhoea in HIV-1 infected individuals.

Authors:  Bas B Oude Munnink; Marta Canuti; Martin Deijs; Michel de Vries; Maarten F Jebbink; Sjoerd Rebers; Richard Molenkamp; Formijn J van Hemert; Kevin Chung; Matthew Cotten; Fransje Snijders; Cees J A Sol; Lia van der Hoek
Journal:  BMC Infect Dis       Date:  2014-01-13       Impact factor: 3.090

9.  Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study.

Authors:  Nicola Richardson-Harman; Craig W Hendrix; Namandjé N Bumpus; Christine Mauck; Ross D Cranston; Kuo Yang; Julie Elliott; Karen Tanner; Ian McGowan; Angela Kashuba; Peter A Anton
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.